153 related articles for article (PubMed ID: 38901890)
1. The evidence base for ICS/formoterol maintenance and reliever therapy in severe asthma.
Beasley R; Noble J; Weatherall M
Eur Respir J; 2024 Jun; 63(6):. PubMed ID: 38901890
[TBL] [Abstract][Full Text] [Related]
2. ICS/formoterol maintenance and reliever therapy: how far beyond asthma?
Beasley R; Bruce P; Hatter L
Thorax; 2023 May; 78(5):430-431. PubMed ID: 36863775
[No Abstract] [Full Text] [Related]
3. The ICS/Formoterol Reliever Therapy Regimen in Asthma: A Review.
Beasley R; Bruce P; Houghton C; Hatter L
J Allergy Clin Immunol Pract; 2023 Mar; 11(3):762-772.e1. PubMed ID: 36639054
[TBL] [Abstract][Full Text] [Related]
4. The effect of budesonide/formoterol maintenance and reliever therapy on the risk of severe asthma exacerbations following episodes of high reliever use: an exploratory analysis of two randomised, controlled studies with comparisons to standard therapy.
Buhl R; Kuna P; Peters MJ; Andersson TL; Naya IP; Peterson S; Rabe KF
Respir Res; 2012 Jul; 13(1):59. PubMed ID: 22816878
[TBL] [Abstract][Full Text] [Related]
5. Satisfaction with single maintenance and reliever therapy or as-needed combined inhaled corticosteroid-formoterol in adults with asthma.
LaCava AF; Gleeson PK; Apter AJ
J Allergy Clin Immunol Pract; 2023 Mar; 11(3):952-954.e1. PubMed ID: 36470520
[No Abstract] [Full Text] [Related]
6. Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children.
Cates CJ; Karner C
Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD007313. PubMed ID: 23633340
[TBL] [Abstract][Full Text] [Related]
7. As needed ICS/formoterol: not all of Europe is equal.
Bush A; Randerath W; Roche N
Eur Respir J; 2024 May; 63(5):. PubMed ID: 38806204
[No Abstract] [Full Text] [Related]
8. A Call for the United States to Accelerate the Implementation of Reliever Combination Inhaled Corticosteroid-Formoterol Inhalers in Asthma.
Krings JG; Gerald JK; Blake KV; Krishnan JA; Reddel HK; Bacharier LB; Dixon AE; Sumino K; Gerald LB; Brownson RC; Persell SD; Clemens CJ; Hiller KM; Castro M; Martinez FD
Am J Respir Crit Care Med; 2023 Feb; 207(4):390-405. PubMed ID: 36538711
[No Abstract] [Full Text] [Related]
9. The Role of ICS-Containing Rescue Therapy Versus SABA Alone in Asthma Management Today.
Krings JG; Beasley R
J Allergy Clin Immunol Pract; 2024 Apr; 12(4):870-879. PubMed ID: 38237858
[TBL] [Abstract][Full Text] [Related]
10. As-needed Dual Inhaled Corticosteroid-Formoterol in Mild Asthma: Scientific Evidence.
Beasley R; Ferreira DS; Papi A
Arch Bronconeumol; 2024 Apr; 60(4):197-199. PubMed ID: 38326118
[No Abstract] [Full Text] [Related]
11. A simple and effective evidence-based approach to asthma management: ICS-formoterol reliever therapy.
Levy ML; Beasley R; Bostock B; Capstick TG; Crooks MG; Fleming L; Freeman D; Marsh V; Rupani H; Whittamore A; Barnes PJ; Bush A
Br J Gen Pract; 2024 Feb; 74(739):86-89. PubMed ID: 38272684
[No Abstract] [Full Text] [Related]
12. Budesonide/Formoterol or Budesonide/Albuterol as Anti-Inflammatory Reliever Therapy for Asthma.
Lipworth B; Kuo CR; Stewart K; Chan R
J Allergy Clin Immunol Pract; 2024 Apr; 12(4):889-893. PubMed ID: 38346474
[TBL] [Abstract][Full Text] [Related]
13. The management of mild asthma.
O'Byrne PM; Reddel HK; Beasley R
Eur Respir J; 2021 Apr; 57(4):. PubMed ID: 33093120
[TBL] [Abstract][Full Text] [Related]
14. Availability of the combination of formoterol and budesonide in the United States of America.
Blango CM; O'Brien CD
Allergy Asthma Proc; 2008; 29(4):426. PubMed ID: 18702893
[No Abstract] [Full Text] [Related]
15. Budesonide/formoterol maintenance and reliever therapy via Turbuhaler versus fixed-dose budesonide/formoterol plus terbutaline in patients with asthma: phase III study results.
Atienza T; Aquino T; Fernández M; Boonsawat W; Kawai M; Kudo T; Ekelund J; Ivanov S; Carlsson LG
Respirology; 2013 Feb; 18(2):354-63. PubMed ID: 23126237
[TBL] [Abstract][Full Text] [Related]
16. Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study.
Vogelmeier C; Naya I; Ekelund J
Clin Drug Investig; 2012 Jul; 32(7):439-49. PubMed ID: 22607479
[TBL] [Abstract][Full Text] [Related]
17. ICS-formoterol reliever therapy stepwise treatment algorithm for adult asthma.
Beasley R; Braithwaite I; Semprini A; Kearns C; Weatherall M; Harrison TW; Papi A; Pavord ID
Eur Respir J; 2020 Jan; 55(1):. PubMed ID: 31919194
[No Abstract] [Full Text] [Related]
18. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
Frois C; Wu EQ; Ray S; Colice GL
Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
[TBL] [Abstract][Full Text] [Related]
19. Fixed or adjustable maintenance-dose budesonide/formoterol compared with fixed maintenance-dose salmeterol/fluticasone propionate in asthma patients aged >or=16 years: post hoc analysis of a randomized, double-blind/open-label extension, parallel-group study.
Aalbers R
Clin Drug Investig; 2010; 30(7):439-51. PubMed ID: 20528000
[TBL] [Abstract][Full Text] [Related]
20. Asthma control with ICS-formoterol reliever versus maintenance ICS and SABA reliever therapy: a post hoc analysis of two randomised controlled trials.
Hatter L; Houghton C; Bruce P; Holliday M; Eathorne A; Pavord I; Reddel HK; Hancox RJ; Braithwaite I; Oldfield K; Papi A; Weatherall M; Beasley R;
BMJ Open Respir Res; 2022 Aug; 9(1):. PubMed ID: 36007980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
